Page 1 of Clinical Trials for Invega, 138 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
A Study of Paliperidone Enantiomer Disposition With Different Formulations and the Bioavailability of Immediate- and Extended-release Paliperidone
Last Updated: June 6, 2011
Condition(s): Schizophrenia
2
Recruiting
Paliperidone ER(Invega®) on Depressive Symptoms of Schizophrenia Patients
Last Updated: May 9, 2012
Condition(s): Schizophrenia
3
Completed
A Study of Paliperidone Blood Concentrations in Patients With Schizophrenia After Administration of Paliperidone Palmitate
Last Updated: April 26, 2010
Condition(s): Schizophrenia
4
Recruiting
Contrasting the Brain Effects of Risperidone and Invega With Functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) Scanning
Last Updated: October 27, 2010
Condition(s): Schizophrenia
5
Completed
A Pharmacokinetic Study of the Relative Bioavailability of Paliperidone ER Formulations With Different Release Profiles and a Comparison to Paliperidone IR
Last Updated: May 17, 2011
Condition(s): Schizophrenia
6
Recruiting
A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Paliperidone Palmitate in Patients With Schizophrenia
Last Updated: May 18, 2012
Condition(s): Schizophrenia
7
Terminated
The Paliperidone ER Observational Study of Economic, Functional, and Clinical Outcomes in Patients With Schizophrenia
Last Updated: May 1, 2012
Condition(s): Schizophrenia
8
Completed
A Study to Evaluate the Response to Treatment and Safety of Flexible Dose Treatment With Paliperidone ER in Patients With Schizophrenia
Last Updated: December 1, 2011
Condition(s): Schizophrenia
9
Not yet recruiting
Paliperidone Palmitate Efficacy and Safety in Bipolar Disorder Complicated by Alcoholism
Last Updated: September 28, 2010
Condition(s): Bipolar Disorder
10
Completed
As Study of the Pharmacokinetics of Paliperidone Extended-release and Risperidone Immediate-release Formulations
Last Updated: June 6, 2011
Condition(s): Schizophrenia; Schizoaffective Disorder
11
Completed
A Safety and Pharmacokinetic Study of ER OROS Paliperidone in Pediatric Patients With Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder
Last Updated: June 6, 2011
Condition(s): Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorders
12
Terminated
A Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone in Schizophrenia Patients and Healthy Controls
Last Updated: April 14, 2011
Condition(s): Schizophrenia
13
Completed
A Safety and Pharmacokinetic Study of Paliperidone Palmitate in Patients With Schizophrenia
Last Updated: June 8, 2011
Condition(s): Schizophrenia
14
Recruiting
Invega for the Treatment of Mania in Children and Adolescents Ages 6-17 With Bipolar Disorder
Last Updated: July 12, 2011
Condition(s): Pediatric Bipolar Disorder
15
Not yet recruiting
Oral Risperidone Versus Injectable Paliperidone Palmitate for Treating First-Episode Schizophrenia
Last Updated: October 11, 2011
Condition(s): Schizophrenia (Recent-onset)
16
Completed
A Study of Plasma Concentrations, Metabolism and Excretion of 14C-paliperidone After a Single Oral Dose
Last Updated: June 6, 2011
Condition(s): Schizophrenia
17
Completed
A Pharmacokinetics and Pharmacodynamics Study Under Fasting and Fed Conditions With Paliperidone Extended-release and Immediate-release Formulations
Last Updated: June 6, 2011
Condition(s): Schizophrenia
18
Completed
A Drug Interaction Study of Valproic Acid and Paliperidone Extended-Release (ER) in Patients With Schizophrenia, Bipolar I Disorder, or Schizoaffective Disorder
Last Updated: March 20, 2012
Condition(s): Schizophrenia; Bipolar Disorder; Psychotic Disorders
19
Completed
Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver Disease
Last Updated: May 18, 2011
Condition(s): Schizophrenia; Schizoaffective Disorder; Psychotic Disorders
20
Completed
Evaluating Patient Satisfaction and Quality of Life When Switching From Risperidone to Paliperidone ER (Extended Release) in Stable But Symptomatic Outpatients With Schizophrenia
Last Updated: February 18, 2010
Condition(s): Schizophrenia

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Invega

Page 1 of Clinical Trials for Invega, 138 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About